| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |